Skip to main content

Table 1 Summary of the TORPEDO trial and post-trial results

From: What drives adoption of a computerised, multifaceted quality improvement intervention for cardiovascular disease management in primary healthcare settings? A mixed methods analysis using normalisation process theory

TORPEDO trial (17.5 months follow-up)

• 25% relative improvement in CVD risk factor screening

• No significant difference in prescribing rates of recommended medicines for people at high CVD risk

• High CVD risk individuals not prescribed optimal recommended treatment at baseline, intervention was associated with 33% relative improvement in prescribing rates

Post-trial phase (18 months follow-up)

• Plateauing of improvement in screening of CVD risk factors

• Ongoing improvement in prescribing of recommended medicines in both the intervention and usual care arm